I TO I Trademark

Trademark Overview


On Tuesday, November 1, 2022, a trademark application was filed for I TO I with the United States Patent and Trademark Office. The USPTO has given the I TO I trademark a serial number of 97657739. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, March 26, 2024. This trademark is owned by Nona Biosciences US, Inc.. The I TO I trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Diagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical p...

Technical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; Medical research; Biological research; Biochemical research and analysis; Testing of pharmaceuticals
i to i

General Information


Serial Number97657739
Word MarkI TO I
Filing DateTuesday, November 1, 2022
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, March 26, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 30, 2024

Trademark Statements


Goods and ServicesDiagnostic preparations for medical purposes; Drug delivery agents in the form of powders, tablets, capsules, solutions, cells and nanoparticles that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Tumor suppressing agents; Pharmaceutical products for the prevention and treatment of cancer; Medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Chemical preparations for pharmaceutical or medical purposes, namely, for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biological preparations for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor; Biochemical medicines for the prevention and treatment of immune system related diseases and disorders, cancer, infections, endocrine system related diseases and disorders, metabolic diseases and disorders, neurological diseases and disorders, cardiovascular diseases and disorders, musculoskeletal diseases and disorders, tumor
Goods and ServicesTechnical research in the field of pharmaceutical studies; Research and development of new products for others; Scientific investigations for medical purposes; Development of pharmaceutical preparations and medicines; Medical laboratory services; Scientific research in the nature of conducting clinical trials for others; Medical research; Biological research; Biochemical research and analysis; Testing of pharmaceuticals

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, November 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, November 17, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNona Biosciences US, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Party NameNona Biosciences US, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNatick, MA 01760

Trademark Events


Event DateEvent Description
Friday, November 4, 2022NEW APPLICATION ENTERED
Thursday, November 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 16, 2023ASSIGNED TO EXAMINER
Monday, June 26, 2023NON-FINAL ACTION WRITTEN
Monday, June 26, 2023NON-FINAL ACTION E-MAILED
Monday, June 26, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, July 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, December 26, 2023ASSIGNED TO LIE
Tuesday, December 26, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 30, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 30, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 26, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 24, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, September 24, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, September 24, 2024TEAS REQUEST TO DIVIDE RECEIVED
Wednesday, December 4, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL